Historic decision makes Truvada the first drug approved to reduce the risk of HIV infection from sexual contact among HIV-negative individuals at elevated risk of infection
Today, the U.S. Food and Drug Administration approved the use of Gilead’s antiretroviral drug Truvada for HIV prevention — known as pre-exposure prophylaxis (PrEP).
The AIDS Foundation...
Read more...
AIDS Foundation of Chicago “Change My Story” Campaign Debuts Smartphone-Driven Ads to Connect People to HIV Prevention and Care Services
Health Promotion Initiative Uses Website, Video Testimonials, Mobile Messaging to Encourage African American Gay and Bisexual Men and Young Women to Get Tested, Get Care
CHICAGO – To mark National HIV Testing Day, the...
Read more...
No one has to live with uncertainty. That is why, in a city-wide effort, the Step Up, Get Tested campaign has set up free HIV testing in the Chicagoland area for National HIV Testing Day (June 27).
The Step Up, Get Tested campaign aims to test 5,000 Chicagoans through testing events in various locations from now through July 4. Find out where you can be tested today .
...
Read more...
Still confused about PrEP? Don't know what to make of the controversy surrounding it?
Sign up for next week's webinar!
In response to recent news from the FDA regarding the use of the drug Truvada for prevention, Mapping Pathways , AIDS United and the AIDS Foundation of Chicago are presenting a webinar focusing on the ARV-based strategy PrEP (pre-exposure prophylaxis.)...
Read more...
Leading AIDS Advocates Support FDA Approval of Pre-Exposure Prophylaxis (PrEP),
a Promising New HIV Prevention Method, for Men and Women
Written Comments to FDA Advisory Committee Cite Compelling Evidence for PrEP and
Urgent Need for Every Available Tool to End AIDS
New York, May 1, 2012 – In public comments submitted this week, a group of 14 leading...
Read more...
Normal 0 false false false EN-US X-NONE X-NONE MicrosoftInternetExplorer4...
Read more...
This is an open letter to the Food and Drug Administration, urging the priority review of the drug Truvada for use in PrEP (pre-exposure prophylaxis). The AIDS Foundation of Chicago and 25 other organizations signed this letter to counter the AIDS Healthcare Foundation's protest of the FDA regarding this review. T o read the PDF of the letter, with footnotes, click here .
January 25,...
Read more...
Abusive relationships can lead to infection, new study says
September 19, 2011
Ten years ago, when Evany Turk's doctor entered an examination room to tell her that she'd tested positive for HIV, she was devastated.
"I sat there wondering, 'Why me?'" said Turk, now 34. "I'd been in a committed relationship for three years. We had used a condom the entire time because I was...
Read more...
ATLANTA, August 16, 2011 – Just months after an AIDS drug demonstrated reasonable efficacy in preventing HIV infection in controlled clinical trials, seven leading AIDS organizations are urging the U.S. government to act quickly to determine if the results could translate to the real world. Today, at an HIV prevention meeting hosted by the U.S. Centers for Disease Control and Prevention...
Read more...
Staff from the AIDS Foundation of Chicago (AFC) will share best practices in HIV prevention policy and research at the 2011 National HIV Prevention Conference in Atlanta, August 14-17, 2011. Convened by the U.S. Centers for Disease Control and Prevention (CDC), the biannual conference gathers thousands of researchers, public health officials, and advocates to share the latest...
Read more...
